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NF-kB (nuclear factorkB) signaling is considered crit-
ical for single positive (SP) thymocyte development
because loss of upstream activators of NF-kB, such
as the IKK complex, arrests their development. We
found that the compound ablation of RelA, cRel,
and p50, required for canonical NF-kB transcription,
had no impact upon thymocyte development. While
IKK-deficient thymocytes were acutely sensitive to
tumor necrosis factor (TNF)-induced cell death, Rel-
deficient cells remained resistant, calling into ques-
tion the importance of NF-kB as the IKK target
required for thymocyte survival. Instead, we found
that IKK controlled thymocyte survival by repressing
cell-death-inducing activity of the serine/threonine
kinase RIPK1. We observed that RIPK1 expression
was induced during development of SP thymocytes
and that IKK was required to prevent RIPK1-kinase-
dependent death of SPs in vivo. Finally, we showed
that IKKwas required to protect Rel-deficient thymo-
cytes from RIPK1-dependent cell death, underscor-
ing the NF-kB-independent function of IKK during
thymic development.
INTRODUCTION
T lymphocytes develop in the thymus from pluripotent bone-
marrow-derived progenitors through an ordered sequence of
developmental events. There has been considerable interest
in identifying those signaling pathways and transcriptional net-
works responsible for controlling different aspects of thymic
development. The nuclear factor kB (NF-kB) family of transcrip-
tion factors is implicated in the function and development of
many tissues and cells (Bonizzi and Karin, 2004). Canonical348 Immunity 50, 348–361, February 19, 2019 Crown Copyright ª 20
This is an open access article under the CC BY license (http://creativeNF-kB signaling is mediated by heterodimers or homodimers
of p50, RelA, and cRel family members that are sequestered
in the cytoplasm by inhibitory proteins, the inhibitors of kappa
B (IkB) family, and related protein p105. Release of canonical
NF-kB dimers is controlled by the inhibitor of kappa B kinase
(IKK) complex, a trimeric complex of two kinases, IKK1 (IKKa)
and IKK2 (IKKb), and a third regulatory component, NEMO
(IKKg). IKK, activated by the upstream TAK1-TAB1 (transform-
ing growth factor [TGF]-b-activated kinase 1 and TAK1-binding
protein 1) kinase complex, phosphorylates IkB, resulting in its
degradation by the proteosome and permitting NF-kB dimers
to enter the nucleus. Previous studies suggest a role for
NF-kB downstream of the preTCR (T cell receptor) complex
in double negative (DN) thymocytes (Voll et al., 2000) and
downstream of the TCR for the selection of CD8 (cluster
of differentiation 8) lineage cells from DP (double positive)
thymocytes (Hettmann and Leiden, 2000; Mora et al., 1999;
Jimi et al., 2008). However, it is notable that TCR activation
of the IKK complex is mediated via a signalosome complex
comprising Card11, Bcl10, and Malt1 proteins (the CBM com-
plex) that is not required for thymocyte development (Schmidt-
Supprian et al., 2004).
More recent studies have instead suggested that NF-kB acti-
vation downstream of tumor necrosis factor (TNF) superfamily
receptors (Tnfrsf), including TNF receptors (TNFR), is required
during thymopoiesis specifically for development of single posi-
tive (SP) thymocytes. TNF stimulation results in a complex
cascade of signaling events that can result in either cell death
or survival (reviewed in Annibaldi and Meier, 2018; Vandena-
beele et al., 2010a). Ligation of TNFR1 causes recruitment of
TRADD (TNFR1-associated death domain protein), TRAF2, and
the serine/threonine kinase RIPK1. The ubiquitin ligases
TRAF2, cellular inhibitor of apoptosis proteins (cIAP), and the
linear ubiquitin chain assembly complex (LUBAC) add ubiquitin
chain modifications to themselves and to RIPK1, which creates
a scaffold allowing recruitment and activation of the TAK1-
TAB1 and IKK complexes and formation of the so-called TNFR
complex I. Triggering IKK activity in this complex results in19 Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
activation of downstream NF-kB and promotion of cell survival.
A failure to maintain the stability of complex I results in the
formation of one of several cell-death-inducing complexes.
Complex IIa is composed of TRADD, FADD (Fas-associated
protein with death domain), and caspase-8 (Micheau and
Tschopp, 2003; Wang et al., 2008), whereas in the presence
of inhibitor of apoptosis protein (IAP) inhibitors, IKK inhibitors,
or TAK1 inhibitors (Dondelinger et al., 2013, 2015; Legarda-
Addison et al., 2009), additional recruitment of RIPK1 allows
formation of related complex IIb. Both of these complexes
induce apoptosis; in the former case it is RIPK1-kinase-activity
independent, whereas in the latter case it is RIPK1-kinase
dependent (Annibaldi and Meier, 2018; Dondelinger et al.,
2016; Ting and Bertrand, 2016). In the absence of caspase-8
protease activity, RIPK3 and MLKL (mixed lineage kinase
domain like pseudokinase) can be recruited to complex IIb and
together trigger a distinct form of cell death termed necroptosis
(for review see Pasparakis and Vandenabeele, 2015; Vandena-
beele et al., 2010b).
The evidence that NF-kB signaling is required during SP devel-
opment largely comes from disruptions to complex I formation.
Ablation of the IKK complex, either by deletion of NEMO
(Schmidt-Supprian et al., 2003) or by combined loss of IKK1
and IKK2 subunits (Webb et al., 2016), results in a developmental
arrest in SP thymocytes at the immature HSAhi stage. Similarly,
an absence of TAK1 and LUBAC results in similar blocks in SP
thymocyte development (Liu et al., 2006; Teh et al., 2016; Wan
et al., 2006). TNF is implicated as a key trigger of these pathways
because its blockade in vivo almost completely rescues SP
development in IKK-deficient thymocytes (Webb et al., 2016)
and rescues survival of TAK1-deficient thymocytes (Xing et al.,
2016). Together, these studies suggest that TAK1- and IKK-
dependent activation of NF-kB by TNF is required for thymocyte
survival. Acquisition of proliferative competence by SP thymo-
cytes is also suggested to require NF-kB signaling because
TAK1-deficient thymocytes do not proliferate in response to
TCR triggering, a defect rescued by expression of a constitu-
tively active IKK2 transgene (Xing et al., 2016). Although these
studies find clear NF-kB gene transcription profiles amongst
SP thymocytes, it remains unclear which gene targets are func-
tionally relevant for SP thymocyte development and survival or
how cell death is controlled when complex I formation is
compromised. One NF-kB gene target that has been functionally
validated in thymocytes, however, is Il7r (Miller et al., 2014; Silva
et al., 2014). Expression of interleukin-7 receptor (IL-7R) by
newly developed T cells is triggered by signals from Tnfrsf mem-
bers, including TNFR1 and CD27, and is dependent upon NF-kB
signaling. Although Il7r gene induction is initiated in mature
SP thymocytes, it is not required for SP development and
only reaches maximal abundance in newly developed T cells
after leaving the thymus. This induction of IL-7R expression is,
however, essential for long-term survival of naive T cells (Silva
et al., 2014).
NF-kB signaling has therefore been implicated in multiple
developmental processes throughout thymopoiesis, but most
specifically in post-selection thymocytes: (1) to protect thymo-
cytes from cell death triggered by TNF, (2) for differentiation of
SP thymocytes into functionally competent cells with migratory
capacity, and (3) for homeostatic maturation of newly developedT cells, mediated in part by induction of IL-7R. In the present
study, we sought to better understand how the IKK complex
and NF-kB signaling downstream of TNF control SP thymocyte
development and reveal RIPK1 as a central regulator of post-se-
lection thymocyte death, survival, and maturation.
RESULTS
Development and Survival of SP Thymocytes Does Not
Depend on NF-kB
To directly ask whether NF-kB signaling is required for SP
thymocyte development, we generated mice with compound
deficiencies of the three Rel family members required for ca-
nonical NF-kB signaling: RelA, cRel, and p50. Cd4Cre Relafx/fx
(RelADT) mice, Nfkb1/ mice that lack p105 and p50, and
Rel/ mice that are cRel deficient were intercrossed, gener-
ating different combinations of Rel subunit deficiency. Thymic
development of CD4 and CD8 SP thymocytes was largely
normal in the different compound mutants, which had normal
phenotypes and numbers of immature HSAhiCD62Llo and
mature HSAloCD62Lhi SP thymocytes (Figures 1A and 1B).
The exception was Nfkb1/ thymocytes, which exhibited per-
turbed CD8-lineage development (Figure 1B), as previously
described (Gugasyan et al., 2012). To confirm that canonical
NF-kB signaling was absent in RelADT Rel/ Nfkb1/ triple-
deficient thymocytes, we first tested their capacity to proliferate
in response to CD3+CD28 stimulation. SP thymocytes from
RelADT Rel/ Nfkb1/ donors were, as expected, unrespon-
sive to CD3+CD28 cross-linking (Figure 1C). We then analyzed
gene expression by RelADT Rel/ Nfkb1/ CD8 SP thymo-
cytes. We have previously identified a number of NF-kB gene
targets by transcriptional profiling of CD8 SP thymocytes from
Chukfx/fx Ikbkbfx/fx huCD2iCre (IKKDTCD2) mice (Webb et al.,
2016). Comparing gene expression between RelADT Rel/
Nfkb1/ and IKK-deficient CD8 SP thymocytes revealed a
very similar pattern of gene regulation (Figure 1D). Previously
defined targets such as IAPs, Traf1 (TNF receptor associated
factor 1), Il7r, Bcl3 (B-cell lymphoma 3-encoded protein),
Tnfaip3 (TNF alpha induced protein 3, A20), and Nfkbia were
all similarly reduced in both strains. Conversely, genes relevant
to TNF signaling but not found to be regulated in IKK-deficient
thymocytes, such as Diablo, Cflar, Cyld, and Xiap, were also un-
affected in RelADT Rel/ Nfkb1/ cells. Additionally, we found
that expression of both Relb and Nfkb2, associated with alter-
native NF-kB activation, appeared to be dependent on canoni-
cal NF-kB signaling because their mRNA abundance was
substantially reduced in both IKK-deficient and RelADT Rel/
Nfkb1/ deficient mice. So, although only canonical Rel com-
ponents were genetically targeted in RelADT Rel/ Nfkb1/
mice, thymocytes, in fact, lacked expression of all five subunits.
Finally, we asked whether Rel-subunit-deficient thymocytes
were more sensitive to TNF-induced cell death than controls
were. Previous studies have suggested that thymocyte survival
is dependent upon NF-kB activation, specifically to protect cells
from TNF-induced cell death (Webb et al., 2016; Xing et al.,
2016). However, all thymic SP subsets in RelADT Rel/
Nfkb1/ hosts were resistant to TNF-induced cell death,
even at supra-physiologic concentrations (Figure 1E), despite
a complete inability to transmit canonical NF-kB signals.Immunity 50, 348–361, February 19, 2019 349
Figure 1. Normal Thymocyte Development and Resistance to TNF-Induced Cell Death in the Absence of Canonical NF-kB Signaling
(A) The phenotype of the indicated thymic populations (rows) from the indicated strains (columns), displayed as 2D plots of relative fluorescence of the indicated
marker. See STAR Methods for electronic gating strategies.
(B) Total numbers of the indicated SP thymocyte subsets recovered from compound mutants of Rela, Nfkb1, and Rel, as indicated in the axis labels. +, WT, – ,
deficient. Numbers of mice (n) per group are indicated in first bar chart.
(C) CTV (cell trace violet) dilution by CD4+ and CD8+ SP thymocytes from the indicated strains stimulated as indicated for 72 h.
(D) Gene expression (normalized reads per kb exons permillion reads, nRPKM) by CD8+ SP thymocytes fromWT (n = 8) and RelADTNfkb1/Rel/mice (RelTKO)
(n = 5) was determined by RNA-seq analysis. Previously published RNA-seq of Tnfrsf1a/ IKKDTCD4 TCRhi CD8+ SP thymocytes (n = 4; Webb et al., 2016) was
included in the analysis.
(E) Total thymocytes from RelADT Nfkb1/ Rel/ and WT controls were cultured for 24 h with different doses of TNF. Graphs show percentage of dead cells.
Data are pooled from six independent experiments (A and B) or are representative of three independent experiments (C and E). Error bars indicate SD.
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Homeostatic Maturation of Newly Developed T Cells Is
NF-kB Dependent
Because NF-kB was not required for thymocyte survival in
response to TNF, we wanted to confirm whether NF-kB was
indeed responsible for homeostatic maturation of T cells, as sug-
gested by previous studies (Miller et al., 2014; Silva et al., 2014;
Webb et al., 2016). To assess homeostatic maturation of T cells,
we analyzed both total numbers of naive peripheral T cells and
IL-7R expression in different Rel-subunit-deficient strains
because Il7r is an NF-kB target gene in SP thymocytes and
peripheral T cells (Miller et al., 2014; Silva et al., 2014). Mice lack-
ing only RelA, only p105, or both p105 and cRel all had normal
naive T cell numbers, although there was evidence of a modest
reduction in IL-7R expression (Figure 2A). However, both naive
T cell numbers and IL-7R expression were substantially reduced
in mice lacking both p105 and RelA, whereas combined
RelA, cRel, and p105 deficiency resulted in the most profound
loss of naive T cells and IL-7R expression. Importantly, the extent
to which naive T cell numbers and IL-7R abundance was
reduced in RelADT Rel/ Nfkb1/ hosts closely resembled
that of Tnfrsf1a/ Chukfx/fx Ikbkbfx/fx Cd4Cre (Tnfrsf1a/
IKKDTCD4) mice. Together, these data confirm that NF-kB is
essential for homeostatic maturation of newly developed
T cells, permitting maximal induction of IL-7R and survival of
naive T cells. These experiments also provided evidence of
Rel-subunit specificity in this process because RelA alone was
sufficient for generation of normal naive T cell numbers, whereas
cRel was not.
Finally, we assessed functional differentiation of SP thymo-
cytes and T cells in Rel-deficient mice because acquisition of
proliferative capacity by developing thymocytes is thought to
be NF-kB dependent (Xing et al., 2016). We first examined
memory and regulatory T (Treg) cell populations. Thymic devel-
opment of Treg cells and generation of peripheral memory
CD4+ T cells are both highly reliant upon cRel (Isomura et al.,
2009; Zheng et al., 2003). Analysis of Rel/ Nfkb1/ mice
confirmed the findings of these earlier studies but also revealed
that although both populations were greatly reduced, they were
not completely absent. In contrast, RelADT Rel/Nfkb1/mice
were almost completely devoid of both Treg and CD4+ memory
T cells (Figures 2B and 2C). Thymocytes from RelADT Rel/
Nfkb1/ mice failed to proliferate in response to TCR stimula-
tion in vitro (Figure 1C). However, it was unclear whether the
absence of CD4+memory T cells in this strain was because naive
T cells were functionally immature in the absence of NF-kB
signaling in the thymus or because unresponsiveness simply
reflected a non-redundant requirement for NF-kB signaling
downstream of TCR in order to activate T cells and generate
memory T cells. To address this question further, we assessed
proliferative responses of thymocytes and peripheral T cells
from IKK1-deficient donors in the presence of an IKK2 inhibitor.
IKK1 deficiency alone has little impact upon thymocyte develop-
ment (Chen et al., 2015), and so the impact of complete IKK
blockade in mature T cells can be assessed. Responses to
CD3 cross-linking by both thymocytes and peripheral T cells
from IKK1-deficient mice was largely normal (Figure 2D). Block-
ing IKK2 in wild-type (WT) thymocytes had a modest effect on
proliferation, whereas in IKK1-deficient thymocytes, additional
blockade of IKK2 resulted in a profound inhibition of cell division,as expected (Figure 2D). However, a similar block in proliferation
was also observed when otherwise responsive peripheral T cells
from IKK1-deficient mice were activated in the presence of an
IKK2 inhibitor. Therefore, the failure of IKK-deficient and Rel-
deficient thymocytes and peripheral T cells to proliferate in
response to TCR triggering most likely reflects an absolute
requirement for this signaling pathway downstream of TCR
triggering rather than a developmental defect.
GeneDose ofChuk and IkbkbRevealsDistinct Functions
for the IKK Complex in Thymocyte Survival and
Maturation
The finding that NF-kB was not required for thymocyte survival
appeared contrary to earlier studies showing the critical require-
ment for the IKK complex during SP thymocyte development.
We therefore examined the role of the IKK complex inmore detail
to better understand how both thymocyte survival and homeo-
static maturation are regulated. First, we examined the function
of individual IKK subunits and specifically whether there was a
distinct reliance upon these subunits for thymocyte survival
versus NF-kB-dependent induction of IL-7R. We examined
T cell development in mice with a T-cell-specific deletion of
Chuk or Ikbkb genes and in compound mutants expressing
only single copies of either gene. Analyzing SP thymocyte com-
partments of mice lacking both Chuk and Ikbkb (IKKDT) (Fig-
ure 3A) confirmed results of earlier studies reporting a profound
loss of mature HSAlo CD4+ and CD8+ SP T cell subsets in mice
lacking IKK function (Schmidt-Supprian et al., 2003; Webb
et al., 2016). Both IKK1 and IKK2 alone were sufficient for normal
thymocyte survival because numbers of SP subsets inmice lack-
ing either of the IKK subunits were normal (Figure 3A). There was
some evidence that IKK2 was more potent than IKK1 at promot-
ing survival. A single Ikbkb gene was sufficient for normal thymo-
cyte survival in the absence of IKK1, whereas, in contrast, a
single copy of the Chuk gene was sufficient for CD4+, but not
CD8+, SP thymocyte subsets in the absence of IKK2.
To assess the impact of compound Chuk and Ikbkb subunit
deletion upon homeostatic maturation of thymocytes, we
measured the expression of IL-7R in peripheral T cells and the
total number of peripheral naive T cells. Both induction of IL-
7R expression (Figure 3B) and total naive T cell numbers (Fig-
ure 3C) were highly sensitive to compound deletions of Chuk
and Ikbkb alleles, with clear evidence of gene dose effect. While
thymocyte survival was only affected by the complete loss of
both Chuk and Ikbkb, normal IL-7R expression and maximal
naive T cell numbers required optimal expression of both IKK1
and IKK2. Together, these data reveal that survival of thymo-
cytes and induction of IL-7R have distinct requirements for IKK
activity, implying that IKK mediates these functions by distinct
mechanisms.
RIPK1 Expression Is Developmentally Regulated in SP
Thymocytes
Given the evidence that IKK may regulate survival and matura-
tion of SP thymocyte subsets by distinct mechanisms, we
wished to better understand how TNF signaling was controlled
during thymopoiesis. We performed a meta-analysis of pub-
lished transcriptomics data generated by RNA sequencing
(RNA-seq; Sinclair et al., 2015) to examine the TNF signalingImmunity 50, 348–361, February 19, 2019 351
Figure 2. Homeostatic Maturation of T Cells Is NF-kB Dependent
(A) Total numbers of naive CD4+ and CD8+ T cells and their expression of IL-7R, from lymph node and spleen of the indicated strains (+, WT, –, deficient for
specified locus). DKO (double knockout) -Chukfx/fx Ikbkbfx/fx Cd4cre Tnfrsf1/ strain as control. Numbers ofmice (n) analyzed per group are indicated in the x axis.
(B) Phenotype of total live lymph node cells and CD4+ T cells from the indicated strains, displayed as 2D plots of relative fluorescence of the indicated markers.
(C) Numbers of CD4+ memory T and Treg cells from the indicated strains.
(D) Sorted thymic populations from the indicated strains and total lymph node cells from the same mice were labelled with CTV and stimulated with CD3+CD28
mAb (monoclonal antibody) for 72 h in the presence of IKK2 inhibitor (IKK2i) or vehicle control. Histograms show relative fluorescence of CTV by different subsets.
Data are the pool of six independent experiments (A–C) or are representative of three independent experiments. Error bars indicate SD. Significant differences
versus WT are indicated in (A) and (C).network in subpopulations of developing thymocytes, with
particular attention upon developmental changes in mature SP
thymocytes, because it is in these populations that TNF signaling
appears to have themost impact. TNF signaling activates a num-352 Immunity 50, 348–361, February 19, 2019ber of pathways via a complex cascade of intracellular adaptors,
kinases, and ubiquitinating enzymes (Figure 4A). Analyzing gene
expression in different DP and SP thymocyte subsets revealed
that expression of many of the signaling intermediaries was
Figure 3. Distinct Requirements for IKK1 and IKK2 Expression for
Thymocyte Survival and Peripheral T Cell Homeostasis
(A) Total numbers of thymocyte subsets from mice with combinations of
Chuk and Ikbkb gene deletions indicated in the axis label (+ indicatesWT allele,unchanged as thymocytes underwent differentiation. There were
notable exceptions to this, though, that included Ripk1 and
Casp8, which were up-regulated in total CD8+ SPs and HSAlo
CD4+ SPs, but not in immature HSAhiCD4+ SPs or DP thymocyte
subsets. This pattern of expression correlated well with the
susceptibility of different subsets to TNF-induced cell death,
apparent in the absence of IKK expression. RIPK1 is a serine/
threonine kinase critical for induction of TNF-induced cell death
and is a major survival factor through its scaffold function
involving both NF-kB-dependent and -independent mecha-
nisms (Pasparakis and Vandenabeele, 2015). Similarly, cas-
pase-8 is a target of RIPK1 kinase activity required for induction
of apoptosis by TNF (Dondelinger et al., 2016; Ting and Bertrand,
2016; Vandenabeele et al., 2010a). To confirm the develop-
mental pattern of Ripk1 expression suggested by RNA-seq, we
measured RIPK1 protein abundance at the single-cell level by
flow cytometry (Figure S1). RIPK1 protein was undetectable
amongst the most immature DP thymocyte subsets (DP1 and
DP2), but expression was induced progressively throughout
SP development, reaching maximum abundance in HSAlo SP
subsets (Figure 4B). Because IKK-deficient thymocytes are spe-
cifically susceptible to TNF-induced cell death (Webb et al.,
2016), we also confirmed that the same pattern of RIPK1 expres-
sion was observed in thymocytes from Tnfrsf1a/ IKKDTCD4
mice (Figure 4B) and that RIPK1 was not itself regulated by
NF-kB signaling. The close correlation between RIPK1 abun-
dance and TNF reactivity of thymic subsets suggested that
RIPK1 could be a central regulator of thymocyte survival.
Normal Thymopoiesis, but Reduced Peripheral T Cell
Numbers in the Absence of RIPK1
To better understand the role RIPK1 plays in thymocyte survival
and differentiation, we first analyzed T cell development in the
absence of RIPK1. RIPK1 deficiency is associated with perinatal
lethality (Kelliher et al., 1998). Therefore, we examined mice in
which Ripk1 expression is specifically ablated in T cells, using
a conditional Ripk1fx/fx Cd4cre strain. Analyzing the thymic
phenotype revealed largely normal development in the absence
of RIPK1 expression (Figure 5A), though there was some evi-
dence of a modest reduction in mature HSAloCD62Lhi CD8+ SP
thymocytes in younger mice (Figure 5B). In contrast, the periph-
ery of the Ripk1fx/fx Cd4cre mice was profoundly T cell deficient,
with substantial reductions in numbers of naive CD4+ and CD8+
T cells in both younger and oldermice (Figure 5C). Since RIPK1 is
thought to be required for optimal triggering of NF-kB signaling, it
was possible that a failure to induce normal IL-7R expression
could contribute to the reduction in peripheral T cells. Upregula-
tion of IL-7R by newly developed T cells as they leave the thymus
is NF-kB dependent (Silva et al., 2014), whereas initial induction indicates floxed allele, all mice cre+). Numbers of mice (n) analyzed per
group are indicated in the x axis.
(B) Charts show IL-7R MFI (mean fluorescence intensity) of the indicated
genotype by CD4+ and CD8+ naive T cells.
(C) Total numbers of CD4+ (left) and CD8+ (right) naive T cells recovered from
combined lymph node and spleen of mice with the indicated combinations of
Chuk and Ikbkb deletion.
Data are the pool of eight independent experiments with 3–18 mice per geno-
type. Error bars indicate SD. Significant differences versus WT are indicated.
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Figure 4. RIPK1 Expression Is under Developmental Regulation during Thymopoeisis
(A) Meta-analysis of RNA-seq data (Sinclair et al., 2015). The indicated thymocyte subsets were sorted from WT (n = 3) mice, mRNA was purified, and gene
expression was determined by RNA-seq analysis. Bar charts show mRNA expression (nRPKM) of the indicated genes.
(B) Histograms are of anti-RIPK1 staining of the indicated thymocyte subpopulation as comparedwith isotope staining control. Bar charts are ofMFI of anti-RIPK1
staining or isotype control of the indicated subsets from either WT (n = 4) or Tnfr1/ IKKDTCD4 mice (n = 2).
Data are representative of four independent experiments. Error bars indicate SD. Significant differences in RIPK1 expression between subsets were tested on
pool of WT and Tnfr1-/-IKKDTCD4 data. Please also see Figure S1.following thymocyte selection depends upon signaling of TCR
but not of NF-kB (Silva et al., 2014; Sinclair et al., 2011).
Analyzing IL-7R induction during thymic development of
RIPK1-deficient T cells revealed normal induction following pos-
itive selection but a failure to up-regulate expression in the pe-
riphery (Figure 5D). Together, these data suggest that RIPK1
expression is required for peripheral T cell survival and optimal
NF-kB-dependent induction of IL-7R.
RIPK1 Both Protects and Sensitizes Thymocytes to TNF-
Induced Cell Death
RIPK1 ismost highly expressed by those SP populations that are
dependent upon IKK activity for survival. We therefore asked354 Immunity 50, 348–361, February 19, 2019whether RIPK1 was required to regulate TNF-induced cell death
in developing thymocytes. First, we examined survival of RIPK1-
deficient thymocytes after TNF stimulation. In WT mice, DP and
HSAhi CD4+ SP thymocytes are modestly sensitive to TNF-
induced cell death, whereas other more mature subsets are
resistant (Webb et al., 2016) (Figure 6A). In contrast, RIPK1 defi-
ciency rendered all thymic subsets sensitive to TNF-induced
cell death to the same modest extent observed in DP and
HSAhi CD4+ SP thymocytes (Figure 6A). Therefore, the resis-
tance of HSAlo CD4 SP and CD8+ SP thymocyte subsets to
TNF-induced death was RIPK1 dependent (Figure 6A), and
the weak susceptibility of DP and HSAhi CD4+ SP thymocytes
in WT mice likely reflected the low or absent expression of
Figure 5. Normal Thymocyte Development, but Defective Peripheral
Homeostasis in the Absence of RIPK1 Expression
Ripk1fx/fx Cd4cre and cre littermates were analyzed at 12 and 32 weeks of age.
(A) Phenotype of the indicated thymocyte populations (columns) from cre+ and
cre– Ripk1fx/fx mice at 12 weeks of age, displayed as 2D plots of relative
fluorescence of the indicated marker.
(B) Total cell numbers of thymocytes and the indicated thymic subsets
recovered from cre+ (n = 5) and cre– (n = 5) Ripk1fx/fx mice.
(C)Total numbersofCD4+andCD8+naiveTcells recovered fromspleensofcre+
(n = 3–5) and cre– (n = 3–5) Ripk1fx/fxmice. ***p < 0.001 by two-way ANOVA.
(D) Histograms of relative fluorescence of IL-7R by the indicated lymph node
T cell subsets from representative cre+ and cre– Ripk1fx/fxmice. Average IL-7R
expression by the indicated thymic DP and SP (HSAhi and HSAlo) subsets and
peripheral naive populations of CD4+ and CD8+ lineage cells.
Data are the pool of two independent experiments. Error bars indicate SD.RIPK1. Together, these data suggest that induction of RIPK1
expression during development renders thymocytes protected
from TNF-induced cell death.
Both expression and kinase activity of the IKK complex are
required to protect thymocytes from TNF-induced cell death
(Webb et al., 2016). While RIPK1 expression appeared to protect
mature thymocytes from TNF-induced death, RIPK1 kinase ac-
tivity is also a potent trigger of cell death (Annibaldi and Meier,
2018; Dondelinger et al., 2016; Ting and Bertrand, 2016). We
therefore tested if TNF-induced death was dependent on
RIPK1 kinase activity in thymocytes.We tested this first by sensi-
tizing IKK1-deficient thymocytes to TNF-induced cell death
with an IKK2 inhibitor and asked if RIPK1 kinase inhibitor Necros-
tatin 1 (Nec1) could prevent cell death. Following IKK blockade,
TNF-induced cell death of SP subsets was completely blocked
by the Nec1 inhibitor, whereas death of DP thymocytes by TNF
was not (Figure 6B). Both the maximal extent of cell death and
the concentration of Nec1 required to prevent TNF-induced
death varied between different subsets. Since expression of
RIPK1 differed between thymic populations, it was possible
that cells with a higher abundance of RIPK1 would be more likely
to die, reflected in the maximal extent of death, and/or would
require more Nec1 to block cell death if RIPK1 kinase activity
was a rate-limiting parameter. We therefore calculated half
maximal inhibitory concentrations (IC50s) of Nec1 for individual
subsets (Figure 6C) and compared both maximal extents of
cell death and IC50s with RIPK1 protein levels (Figure 6D). This
revealed strong correlations between RIPK1 abundance and
both maximal cell death (r2 = 0.78) and IC50 of Nec1 (r2 =
0.63). Similarly, we asked whether RIPK1 abundance also pre-
dicted susceptibility to TNF-induced cell death. Correlating
published lethal dose 50 (LD50) of TNF (Webb et al., 2016) with
RIPK1 abundance revealed a strong inverse correlation (r2 =
0.88) (Figure 6D). Populations with the highest abundance of
RIPK1 expression required the least TNF to trigger cell death.
Together, these data show that TNF-induced death of thymo-
cytes in vitro in the absence of IKK activity is RIPK1 dependent
and further suggests that RIPK1 is rate limiting for TNF-induced
cell death amongst SP thymocytes.
IKK Activity Is Required to Prevent RIPK1-Induced Cell
Death Independently of NF-kB Signaling
Our data suggest that RIPK1 is a central regulator of thymocyte
survival and that IKK kinase activity is required to repress RIPK1-
kinase-dependent cell death by a mechanism independent of
NF-kB. Recent studies show that RIPK1 is a direct target of
IKK kinase activity in embryonic fibroblasts and that phosphory-
lation of RIPK1 by IKK represses its kinase activity and subse-
quent induction of cell death (Dondelinger et al., 2015). However,
the significance of this regulatory circuit in vivo is unclear, and
the activity of such an IKK-RIPK1 pathway has not so far been
identified in a physiological setting. To ask whether thymocyte
survival utilizes an NF-kB-independent function of IKK involving
repression on RIPK1 in vivo, we first tested whether the death of
IKK-deficient thymocytes in vivo was dependent upon RIPK1 ki-
nase activity. We generated IKK-deficient mice in which RIPK1
kinase activity was impaired, introducing the inactivating
RIPK1D138N mutation (Newton et al., 2014) to the IKKDThuCD2
strain. In this way, the scaffolding function of RIPK1 is preservedImmunity 50, 348–361, February 19, 2019 355
Figure 6. Induction of RIPK1 Expression Sensitizes Developing
Thymocytes to TNF-Induced Cell Death
(A) Thymocytes from cre+ and cre– Ripk1fx/fx mice were cultured with different
doses of TNF for 24 h, and cell viability was determined by flow cytometry.
Graphs show percentage of dead cells among the indicated thymic subpop-
ulation from cre+ and cre- Ripk1fx/fx mice (n = 3 each). Significance tested by
one-way ANOVA.
(B and C) Total thymocytes from huCD2iCre Chukfx/fx mice were cultured with
IKK2 inhibitor, TNF (10 ng/ml) or PBS, and different doses of RIPK1 kinase
inhibitor Necrostatin-1 (Nec1). Line graphs show percentage of dead cells in
cultures with TNF or PBS (B). Red lines (B) indicate modeled fits used to
identify maximal death in different subsets and to estimate IC50 of Nec1 (C).
Error bars of IC50 estimates indicate 95% confidence intervals.
(D) Scatter plots are of RIPK1 MFI from Figure 4B versus percentage of
induced death (B), Nec1 IC50 estimated in (C), and TNF LD50 for IKK-deficient
thymocytes (Webb et al., 2016). Solid lines are regression fits to data with 95%
confidence indicated (dashed lines).
Data are representative of two (A) or three (B, C, and D) independent exper-
iments.
356 Immunity 50, 348–361, February 19, 2019while its kinase function is inactivated. In IKKDThuCD2 mice,
the expression of kinase-dead RIPK1D138N resulted in a sub-
stantial rescue of SP development and export of T cells into
the periphery. Development of mature HSAloCD62Lhi CD4+
SP and immature HSAhiCD62Llo CD8+ SP thymocytes was
restored to near normal numbers in IKKDThuCD2 RIPK1D138N
mice, while mature HSAloCD62Lhi CD8+ SP thymocytes were
partially rescued (Figures 7A and 7B). Peripheral lymphoid or-
gans of IKKDThuCD2 mice were almost completely devoid of
naive CD4+ or CD8+ T cells (Figures 7C and 7D). The few naive
T cells present were mostly R26RYFP-cre-reporter negative
(Figure 7D) and therefore most likely represented rare deletion
escapants that had failed to excise Ikk genes (Webb et al.,
2016). In contrast, IKKDThuCD2 RIPK1D138N mice contained
significant numbers of naive CD4+ and CD8+ T cells compared
with IKKDThuCD2 mice, which were R26RYFP +ve, confirming
that restoration of thymic development in these mice was
also associated with export of IKK-deficient T cells. However,
RIPK1D138N did not restore peripheral T cell numbers in
IKKDThuCD2 mice to normal (Figure 7D), suggesting that IKK
function was still required for sustained population of periph-
eral compartments.
We next asked whether RIPK1 is phosphorylated following
TNF stimulation of thymocytes and, if so, if it was dependent
upon IKK activity. We first confirmed that RIPK1 phosphorylation
was detectable in WT thymocytes after immunoprecipitation of
complex I. Indeed, deubiquitination and dephosphorylation of
RIPK1 revealed characteristic electrophoretic shifts associated
with ubiquitination and phosphorylation of RIPK1within complex
I after TNF stimulation (Figure 7E). Little phosphorylation of
RIPK1 was detectable when WT thymocytes were preincubated
with a pan-IKK inhibitor (Waelchli et al. 2006), whereas phos-
phorylation was unaffected by Nec1 (Figure 7F). In agreement
with this, little phosphorylation of RIPK1 was detectable after
TNF stimulation of IKK-deficient thymocytes from IKKDThuCD2
RIPK1D138N mice (Figure 7G), all together suggesting that
RIPK1 phosphorylation in response to TNF stimulation is IKK
dependent. Finally, we tested whether survival of RelADT Rel/
Nfkb1/ thymocytes in response to TNF was dependent upon
IKK kinase activity, even though downstream NF-kB activation
was completely absent.Wemeasured survival of TNF-stimulated
Figure 7. Kinase-Dead RIPK1D138N Rescues Thymocyte Development in IKK-Deficient Hosts
(A–D) Phenotype, displayed as 2D plots of relative fluorescence, of thymus (A) and lymph nodes (C) and numbers of the indicated populations of thymocytes (B)
and lymph nodes (D) from the indicated mouse strains.
(E–G) WT thymocytes (E and F) or thymocytes with the indicated genotype (G) were stimulated for 10 min with FLAG-TNF in the presence or absence of the
indicated compounds, and FLAG immunoprecipitates were incubated with deubiquitylating (USP2) or phosphatase (l PPase) enzymes as indicated. Extracts
were analyzed by immunoblotting for RIPK1. Blots are representative of five (E), two (F), or four (G) independent experiments.
(H and I) Total thymocytes fromRelADTNfkb1/Rel/micewere cultured for 24 h with TNF and either IKK2 inhibitor (IKK2i) (H) or a pan IKK inhibitor (panIKKi) (I),
and viability was determined by flow cytometry.
Data are representative (A, C, H, and I) or the pool (B and D) of four or more independent experiments. Error bars indicate SD.
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thymocytes when IKK activity was blocked with two distinct IKK
inhibitors: a specific IKK2 inhibitor, BI605906, that doesnot target
IKK1 and therefore achieves a partial IKK inhibition (Clark et al.,
2011) and a pan IKK inhibitor, IKK16 (Waelchli et al., 2006), that
inhibits both IKK1 and IKK2. Specifically inhibiting IKK2 resulted
in a clear sensitization of mature HSAlo SP thymocytes to TNF-
induced cell death (Figure 7H), whereas culture with pan-IKK in-
hibitor rendered all SP populations sensitive to TNF-induced cell
death (Figure 7I). To test whether cell death of RelADT Rel/
Nfkb1/ thymocytes following IKK inhibition was also RIPK1
dependent, cells were additionally cultured with Nec1. Impor-
tantly, TNF-induced cell death in the presence of IKK2 inhibition
was completely blocked by Nec1, whereas death in cultures
with IKK16 was substantially reduced by blocking RIPK1 kinase
(Figures 7Hand7I), revealing that IKKdoes regulateRIPK1kinase
activity even in the absence of NF-kB. Taken together, our data
suggest that IKK regulates thymocyte survival by repressing
RIPK1 kinase activity by a mechanism that does not rely upon
NF-kB activation.
DISCUSSION
Here, we found that mice lacking canonical NF-kB signaling in
T cells undergo unperturbed thymic development and were
resistant to TNF-induced cell death, even at supra-physiologic
concentrations. Although it is clear that NF-kB activation is
essential to control cell death processes in other tissues, such
as hematopoietic progenitors and endothelial cells (Xu et al.,
2018), this does not appear to be the case in thymocytes. Mice
lacking upstream regulators of NF-kB activity, such as the IKK
complex or TAK1, reveal a profound block in SP thymocyte
development and were used to implicate NF-kB as an important
downstream target mediating SP thymocyte development. We
observed unperturbed SP development in RelADT Rel/
Nfkb1/ mice, with normal downregulation of HSA and induc-
tion of CD62L, thymic egress, and population of peripheral
compartments. Transcriptomic analyses reveal a clear NF-kB-
dependent gene signature in developing SP thymocytes (Webb
et al., 2016; Xing et al., 2016), including genes that regulate cell
survival, so it was natural to conclude that such genes should
be responsible for resistance to TNF-induced cell death. How-
ever, our results clearly demonstrate that acute survival of thy-
mocytes does not depend upon NF-kB regulated genes.
Instead, we identified a critical role for an IKK-RIPK1 signaling
axis for controlling the survival of developing thymocytes. Our
data suggest that IKK expression and kinase activity are essen-
tial to prevent TNF-induced RIPK1-mediated cell death in vivo.
We showed that RIPK1 expression is induced during thymopoi-
esis reaching peak abundance in SP thymocytes after positive
selection, and it is in these subsets that this pathway was most
critical. In the absence of IKK function, induction of RIPK1
expression in HSAlo CD4+ SP and CD8+ SP thymocytes coin-
cided with extensive cell death of these specific subsets. Block-
ing RIPK1 kinase activity, both in vitro with inhibitors and in vivo
in mice expressing kinase-dead RIPK1, rescued survival of these
populations, revealing that repression of RIPK1-kinase-depen-
dent cell death was the target of IKK kinase activity. However,
we also found evidence, paradoxically, that RIPK1 expression
may also have a protective function in thymocytes. In WT358 Immunity 50, 348–361, February 19, 2019mice, DP thymocytes expressed little or no RIPK1 but were
weakly sensitive to TNF-induced cell death. We confirmed that
cell death was RIPK1 independent because RIPK1-deficient
DP cells exhibited similar extents of cell death in response to
TNF. What is more, RIPK1-deficient thymocytes maintained a
similar, modest susceptibility to TNF-induced death throughout
DP and SP development, in contrast to WT thymocytes that
became resistant to TNF-induced cell death as RIPK1 expres-
sion was induced. This modest extent of TNF-induced death
may reflect the TNFR complex IIa formation that occurs in the
absence of RIPK1. Therefore, induction of RIPK1 expression
may protect developing thymocytes from TNF-induced cell
death by preventing complex IIa formation but also necessitates
IKK activity to prevent the more potent activity of RIPK1-kinase-
dependent, complex-IIb-mediated cell death in its place.
The most direct interpretation of our data is that IKK activity
is required to repress RIPK1-kinase-dependent cell death inde-
pendently of NF-kB. In support, studies in mouse embryonic
fibroblasts reveal that the IKK complex can directly regulate
RIPK1 during the assembly of the TNFR complex I. Phosphory-
lation of RIPK1 by IKK prevents its activation and consequently
its integration into the death-inducing complex IIb (Dondelinger
et al., 2015). The same study found that either IKK1 or IKK2 alone
were sufficient for this regulatory function upon RIPK1. Consis-
tent with this, survival of thymocytes lacking either IKK1 or
IKK2 was normal, though we found evidence that IKK2 was a
more potent regulator of RIPK1 because a single functional allele
of Ikbkb, but notChuk, was sufficient to protect thymocytes from
TNF-induced death. Of significance, RIPK1 phosphorylation is
also defective in the absence of cIAPs, TAK1, and NEMO (Don-
delinger et al., 2015; Geng et al., 2017). Therefore, it seems that
the block in SP thymocyte development observed in LUBAC-
(Teh et al., 2016), TAK1-, and NEMO-deficient mice (Schmidt-
Supprian et al., 2003; Teh et al., 2016; Xing et al., 2016) results
from disruption of the delicate equilibrium of pro-death and
pro-survival TNFR signaling complexes rather than from their
common function of activating NF-kB. The potency of IKK2 in
controlling RIPK1 may also be of relevance to the application
of constitutively active IKK2 constructs, often used to reconsti-
tute NF-kB signaling. It is possible that some functions of these
constructs may instead be mediated by their direct targeting
of RIPK1.
Our data suggest that acute survival of developing thymocytes
is regulated by a direct IKK-RIPK1 pathway. If so, what function
does NF-kB signaling then play during thymic development?
Although it has been suggested that NF-kB signaling in devel-
oping SP thymocytes is critical for their acquisition of prolifera-
tive capacity to TCR stimulation (Xing et al., 2016), our results
were equivocal on this point. Thymocytes were unable to prolif-
erate in response to TCR triggering in the absence of either
canonical NF-kB or IKK kinase activity. However, it was also
clear that in normally peripheral T cells, blocking IKK kinase
had the same impact upon proliferation, confirming that an intact
IKK-NF-kB pathway is critical for normal responses to TCR
triggering. Therefore, there is currently no evidence that the fail-
ure to trigger cell division in thymocytes with defective NF-kB
activation represents anything other than an acute requirement
for this pathway downstream of TCR stimulation. To test whether
NF-kB activity in developing thymocytes is required for their
proliferative competence will require alternative approaches that
can separate the acute requirement for NF-kB activation down-
stream of TCR from developmental programming.
Although NF-kB appears dispensable for normal thymocyte
survival, our data strongly suggest that one function of NF-kB
in newly developed T cells is instead to trigger a program of ho-
meostatic maturation required for long-term survival of mature
peripheral T cells. This function is clearly revealed in mice in
which NF-kB signaling is absent and RIPK1-induced cell death
is held in check. In such cases, thymocyte development and
egress are largely normal, but peripheral T cells fail to survive
long term and accumulate. Common to these strains is a failure
of peripheral T cells to maintain high abundance of IL-7R,
whose gene is a key NF-kB target required for their survival
(Silva et al., 2014; Webb et al., 2016). However, numerous
pro-survival genes, such as cIAPs, are targets of NF-kB
signaling in the thymus (Webb et al., 2016), and although these
have been originally thought to mediate acute survival of
thymocytes, they might instead be more important for the
long-term survival of peripheral T cells. Studies in which embry-
onic lethality of RIPK1 deficiency is rescued by elimination of
caspase-8 or FADD in combination with either RIPK3 or
MLKL (Dillon et al., 2014; Rickard et al., 2014) also suggest
that thymopoeisis is normal in the absence of death machinery
and have peripheral T cells that can mount anti-viral responses
(Kaiser et al., 2014). However, the gross perturbations to the
T cell compartment that occur in such mice in the absence of
Fas signaling make it hard to assess whether T cell maturation
is normal. Here, we observed a significant reduction in IL-7R
expression following T-cell-specific deletion of RIPK1. The
defect was more modest than in other strains that completely
lacked NF-kB activity, suggesting that NF-kB activation down-
stream of TNFRSF signaling is not entirely RIPK1 dependent in
thymocytes. However, the peripheral lymphopenia was as
profound as other strains lacking NF-kB signaling. Our data
suggest that thymocytes are weakly susceptible to TNF-
induced cell death independently of RIPK1, possibly mediated
by TNFR complex IIa. It is possible that the activity of this com-
plex is enhanced as caspase-8 expression is upregulated in
mature SP thymocyte subsets, which, in combination with
reduced IL-7 survival signaling and other pro-survival NF-kB
targets, results in the profoundly atrophied peripheral T cell
compartment observed.
Our data reveal that RIPK1 expression is under developmental
regulation in T cells, reaching peak abundance only in the most
mature thymic populations. While RIPK1 is a critical component
of the necroptosome, thymocytes do not express MLKL and are
therefore not susceptible to necroptosis. Consistent with this,
caspase-8-deficient T cells only become susceptible to necrop-
tosis after TCR triggering (Ch’en et al., 2011). Taken together,
this suggests that death signaling in T cells is developmentally
regulated. In thymocytes, RIPK1 expression is induced, but at
this stage its physiological role is to transmit TNFRSF signals
required for normal NF-kB activation and maturation of new
T cells. It is not until T cells become activated that RIPK1 can
additionally mediate host defense functions by triggering nec-
roptosis in susceptible cells, for instance during viral infections
(Mocarski et al., 2011). Whether RIPK1 continues to facilitate
transmission of TNFRSF-derived signals that are important indevelopment of effector and memory responses will be an
important area of future research.
Finally, expression of kinase-dead RIPK1D138N in vivo resulted
in a near-complete rescue of IKK-deficient CD4 SP thymocytes
but only a partial rescue of mature CD8 SP thymocytes. While
RIPK1 is one target of IKK responsible for regulating survival of
mature CD8+ SP thymocytes, these data suggest that the IKK
complexmay control survival of these cells by othermechanisms
independent of both RIPK1 and NF-kB. Our data reveal that thy-
mocytes are onlymodestly sensitive to TNF-induced death in the
absence of RIPK1 expression, whereas IKK deficiency renders
them exquisitely sensitive to TNF-induced death, underscoring
a critical role of IKKs in keeping RIPK1-dependent cell death in
check. It may be relevant that TNFR1 deficiency also fails to
completely rescue survival of mature, IKK-deficient CD8+ SP
thymocytes (Webb et al., 2016). This could argue for the involve-
ment of other death receptors, such as DR3, in regulating thymo-
cyte survival. However, given the complexity of the downstream
signalosome responsible for TNFR signaling, together with the
developmental changes in gene expression of key signaling
components such as RIPK1 and caspase-8, it is possible that
removal of one or more components disturbs the fine equilibrium
regulating formation of the different signaling complexes, which
results in spontaneous, ligand-independent signaling. Whatever
the explanation, it is clear that regulation of CD8+ SP thymocyte
survival is complex. Nevertheless, identifying the importance of
NF-kB-independent functions of the IKK complex for thymocyte
survival and specifically the role of the IKK-RIPK1 pathway will
greatly facilitate future studies of IKK-dependent cell survival.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice with conditional alleles of Ikbkb (Ikbkbfx/fx) (Li et al., 2003) and Chuk (Chukfx/fx) (Gareus et al., 2007) were intercrossed with
mice either expressing transgenic cre under the control of the human Cd2 (DThuCD2) (de Boer et al., 2003) or Cd4 expression el-
ements (DTCD4). Rosa26 reporter YFP allele (R26REYFP) (Srinivas et al., 2001) was also used, in order to facilitate identification of
cells in which cre recombinase had been active, while Cd4Cre strains were additionally backcrossed onto a Tnfrsf1a/ back-
ground. Compound mutants of Rela, Nfkb1 and Rel were generated by intercrossing Nfkb1/, Rel/ and Relafx/fx Cd4Cre strains.
Chukfx/fx Ikbkbfx/fx R26REYFP huCD2iCre, Chukfx/fx R26REYFP huCD2iCre, Chukfx/fx Ikk2fx/fx R26REYFP Cd4Cre, Tnfrsf1a/ Chukfx/fx
Ikbkbfx/fx R26REYFP Cd4Cre and Ripk1D138N Chukfx/fx Ikbkbfx/fx R26REYFP huCD2iCre, mice were bred in the Comparative Biology
Unit of the Royal Free UCL campus and at Charles River laboratories, Manston, UK. Ripk1fx/fx Cd4Cre mice were breed at VIB.
Ex vivo analysis of lymphoid organs was performed using mice between 8-12 weeks age unless otherwise specified. All mice
are on a C57BL6/J background. Animal experiments were performed according to the UCL Animal Welfare and Ethical Review
Body and Home Office regulations.
METHOD DETAILS
Flow Cytometry
Flow cytometric analysis was performed with 2-5 x 106 thymocytes, 1-5 x 106 lymph node or spleen cells. Cell concentrations of thy-
mocytes, lymph node and spleen cells were determined with a Scharf Instruments Casy Counter. Cells were incubated with satu-
rating concentrations of antibodies in 100 ml of phosphate-buffered saline (PBS) containing bovine serum albumin (BSA, 0.1%)
and 1 mM azide (PBS-BSA-azide) for 45 min at 4C followed by two washes in PBS-BSA-azide. Phycoerythrin (PE)–conjugated anti-
body against IL-7Ra, EF450-conjugated antibodies against CD4, APC-conjugated antibody against CD5, PE-Cy5– and PerCPcy5.5-
conjugated antibody against TCR (H57-597), APC-Cy7– and APC-conjugated antibody against CD44, pacific orange (PO)–conju-
gated antibody against CD8, PE-Cy7- conjugated antibody against CD25, PE-Cy7-conjugated antibody against HSA(CD24) were
purchased from eBioscience. RIPK1 was detect using 1mg/ml of anti-RIPK1 rabbit monoclonal (D94C12, Cell Signaling Technology)
or isotype control (DA1E, Cell Signaling Technology) and a Alexa Fluor 647 conjugated secondary anti-Rabbit (Cell Signaling Tech-
nology). Cell samples were fixed in 1% PFA for 20 mins at 4C and permeabilised with 0.1% NP40 for 3 mins prior to staining. CellImmunity 50, 348–361.e1–e4, February 19, 2019 e2
viability was determined using LIVE/DEAD cell stain kit (Invitrogen Molecular Probes). Eight-color flow cytometric staining
was analyzed on a FACSCanto II or LSRFortessa X-20 (Becton Dickinson) instrument. For cell sorting, lymphocytes were incubated
with the appropriate antibodies for detection of surface markers and were then purified to >95% purity by high-speed sorting on
an FACSAria flow cytometer (Becton Dickinson). Data analysis and colour compensations were performed with FlowJo V9.5.3
software (TreeStar). Live FSc versus SSc gates were defined following singlet gating on the basis of FSC-A versus FSC-W.
Specific thymocyte populations were gated in the following manner. DP thymocytes – CD4+ CD8+, CD4+ SP thymocytes – CD4+
CD8- TCRhi, CD8+ SP thymocytes – CD4+ CD8- TCRhi. Peripheral populations in lymph node and spleen were gated as follows.
CD4+ T cells – CD4+ CD8- TCRhi, CD8+ T cells – CD4+ CD8- TCRhi, Naive CD4+ T cell – CD4+ TCRhi CD44lo Foxp3-, Naive CD8+
T cell – CD8+ TCRhi CD44lo, CD4+ memory – CD4+ TCRhi CD44hi Foxp3-, Treg - CD4+ TCRhi Foxp3+. Data are displayed on log
and biexponential displays of fluorescence intensity in arbitrary units. Axis labels indicates the target protein to which fluorophore
labelled antibodies are specific and fluorescent signal is display. Numbers on plots indicate % of cells falling in the
corresponding gate.
In Vitro Culture
Thymocytes were cultured at 37oC with 5% CO2 in RPMI-1640 (Gibco, Invitrogen Corporation, CA) supplemented with 10% (v/v)
fetal bovine serum (FBS) (Gibco Invitrogen), 0.1% (v/v) 2-mercaptoethanol bME (Sigma Aldrich) and 1% (v/v) penicillin-streptomycin
(Gibco Invitrogen) (RPMI-10). Recombinant TNF was supplemented to cultures at 10ng/ml, unless otherwise stated, and was
obtained fromR&D, with PBS used as vehicle. Inhibitors were used at the following concentrations, unless otherwise stated : specific
IKK2 inhibitor BI605906 (10mM in 0.1% DMSO vehicle), pan IKK inhibitor IKK16 (2mM in 0.1% DMSO), Necrostatin 1 (1mM in 0.1%
DMSO). Cells were activated by CD3 (10mg/ml) and CD28 (10mg/ml) mAb bound to 96 well flat bottom plates overnight at 4C
and washed with PBS prior to culture. Cells were cultured at 106/ml in 200ml. TCRhi CD4+ SP and CD8+ SP thymocytes were isolated
by cell sorting from total thymocytes, labelled with CTV and cultured at 106/ml for 72hr in either CD3+CD28 mAb coated plates or
uncoated wells as control. Cultures of peripheral T cells were performed by labelling total lymph node cell suspensions with CTV
and culturing cells at 106/ml in 96 well flat bottom plates.
RNA-Seq Analysis
TCRhi CD8+ SP thymocytes were sorted fromWT (n = 8) and RelADTNfkb1/Rel/mice (n = 5), mRNA purified and gene expression
determined by RNAseq analysis. Individual RNAseq libraries were generated from independent cell preparations. RNA was isolated
from single cell suspensions using the RNeasy Mini Kit (Qiagen) according to the manufacturer’s instructions. RNA integrity was
confirmed using Agilent’s 2200 Tapestation. Samples were processed using the SMART-Seq v4 Ultra Low Input RNA Kit
(Clontech Laboratories, Inc.). Briefly, cDNA libraries were generated using the SMART (Switching Mechanism at 5’ End of RNA
Template) technology which produces full-length PCR amplified cDNA starting from 10ng total RNA. The amplified cDNA was
checked for integrity and quantity on the Agilent Bioanalyser using the High Sensitivity DNA kit. 150pg of cDNA was then converted
to sequencing library using the Nextera XT DNA (Illumina, San Diego, US). This uses a transposon able to fragment and tag the
double-stranded cDNA (Tagmentation), followed by a limited PCR reaction (12 cycles). Libraries to be multiplexed in the same
run are pooled in equimolar quantities, calculated from Qubit and Tapestation fragment analysis. Samples were sequenced on
the NextSeq 500 instrument (Illumina, San Diego, US) using a 43bp paired end run.
Run data were demultiplexed and converted to fastq files using Illumina’s bcl2fastq Conversion Software v2.19. Fastq files are
pre-processed to remove adapter contamination and poor quality sequences (trimmomatic v0.36) before being mapped to a
suitable reference genome using the spliced aligner STAR (v2.5b). Mapped data is deduplicated using Picard Tools (v2.7.1), in
order to remove reads that are the result of PCR amplification, and remaining reads per transcript are counted by FeatureCounts
(v1.4.6p5). Normalisation, modelling and differential expression analysis are then carried out using SARTools (v1.3.2), an integrated
QC and DESeq2 BioConductor wrapper. After normalization, reads were displayed as reads per kilobase of exon per million
reads (RPKM).
Immunoblotting and Complex I Immunoprecipitation
3 x 107 total thymocytes were used per condition. Where indicated, cells were pretreated for 30 min with Nec1 and/or IKK16
inhibitors. For complex I immunoprecipitations (IPs), cells were stimulated with 2 mg/ml 3xFLAG-TNF. Cells were washed two times
in ice-cold PBS before lysis in 1 ml of NP-40 lysis buffer (10% glycerol, 1% NP-40, 150 mM NaCl, and 10 mM Tris-HCl [pH 8]
supplemented with phosphatase and protease inhibitor cocktail tablets [Roche Diagnostics]). The cell lysates were cleared by
centrifugation for 15 min at 40C, and the supernatant was then incubated overnight with FLAG M2 affinity gel at 4C. The next
day, the beads were washed three times in PBS buffer. The beads were then either resuspended in 10ml Laemmli buffer to elute
the immune complexes or resuspended in 40ml of DUB/lPP buffer (50 mM Tris-HCl [pH 8], 50 mM NaCl, 5 mM DTT, and 1 mM
MnCl2) to remove conjugated ubiquitin chains and phosphorylations on RIPK1. Then, either 1.8 mg USP2 or 800 U Lambda protein
phosphatase (New England BioLabs) was added as indicated. Reactions were incubated for 30min at 30 C and subsequently 30 min
at 37C. IPs and total cell extract loading controls were analyzed by NuPage 3%–8%Bis-Tris gel (Invitrogen Novex), transferred onto
PVDF membrane (Millipore) and immunoblotted with anti-RIPK1 (Cell Signaling Technology). Immunodetection was performed by
incubation with horseradish peroxidise-conjugated anti-rabbit (1:5000) (DAKO) and developed by enhanced chemiluminescence
(Millipore).e3 Immunity 50, 348–361.e1–e4, February 19, 2019
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis and figure preparation were performed using Graphpad Prism 6 (v6.0a). Two-way comparisons were made by
nonparametric unpaired two-tailed Mann-Witney Student’s t test while dose response curves and variation in cell numbers between
strains over time were analyzed by two-way ANOVA. *p < 0.05, **p < 0.01, ***p < 0.001. Error bars indicate SD unless otherwise
stated.
DATA AND SOFTWARE AVAILABILITY
The accession numbers for the data reported in this paper are ArrayExpress: E-MTAB-4778 and E-MTAB-7470.Immunity 50, 348–361.e1–e4, February 19, 2019 e4
